# Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients

> **NCT02121288** · PHASE4 · WITHDRAWN · sponsor: **AstraZeneca**

## Conditions studied

- Peripheral Artery Disease
- Vascular Disease
- Arterial Occlusion Disease
- Intermittent Claudication
- Ankle Brachial Index (0.9 or Less)

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** clopidogrel

## Key facts

- **NCT ID:** NCT02121288
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-12
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02121288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02121288, "Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02121288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*